The efficacy of dietary Spirulina as an adjunct to chemotherapy to improve immune function and reduce myelosuppression in patients with malignant tumors
Notes for this study:
|Values||Mean and SD. Change. Control: 1.55±5.82 Spirulina 0.56±4.43|
|Trial Design||Randomized trial|
|Number of Subjects||100|
|Age Range||18-29, 30-44, 45-64, 65+|
In a randomized, controlled trial, 100 cancer patients receiving four cycles of chemotherapy took 900 mg of spirulina daily or were in a control group that didn't.
White blood cell count was higher in the spirulina group than the control group during the first two cycles but not the second two. Neutrophilic granulocytes were also higher in the two but not the last two. Hemoglobin was generally higher but not significantly so, and the same could be said of platelets. There was a greater reduction in IgM and CD8+ T cells in the spirulina group. There was also a greater reduction in CD4+ T tells and less of an increase in IgA, and IGG, but the difference wasn't statistically significant. There wasn't a notable difference in C4 or C3.